SOMATOSTATIN-INDUCED CONTRACTION MEDIATED BY ENDOTHELIAL TXA(2) PRODUCTION IN CANINE CEREBRAL-ARTERIES

Whether somatostatin causes endothelium-dependent contraction (EDC) in isolated canine basilar arteries was examined. Somatostatin (10(-8) - 10(-6) M) caused transient contractions in a dose-dependent manner. T hese contractions were abolished by removal of the endothelium, while the contractile response to neuropeptide Y occurred even after removal of the endothelium. The EDC induced by somatostatin (10(-7) M) was af fected by neither atropine (10(-6) M) nor cyclo-somatostatin (10(-5) M ), which suggests that the EDC is not due to release of endogenous ace tylcholine and that the endothelial somatostatin receptor is different from hormonal somatostatin receptors. The somatostatin-induced EDC wa s attenuated by cyclooxygenase inhibitors (aspirin and indomethacin), thromboxane A2 (TXA2) synthetase inhibitors (OKY-064 and RS-5186), and TXA2 antagonists (ONO-3708 and S-145), which suggests that the endoth elium-derived contracting factor is TXA2. These findings demonstrate t hat somatostatin causes EDC via activation of TXA2 synthesis in canine cerebral arteries.